Exploring Dichloroacetate's Metabolic Impact on Colon Cancer Cells via 13C NMR Spectroscopy
ORAL
Abstract
Dichloroacetate (DCA) has shown promise as a therapeutic agent in cancer treatment by targeting the altered metabolism of cancer cells. In this study, we utilized 13C Nuclear Magnetic Resonance (NMR) spectroscopy to explore the metabolic effects of DCA on cultured colon cancer cells. By employing stable isotope-labeled glucose and other substrates, we traced the carbon atoms' journey through key metabolic pathways, offering a comprehensive view of the cellular metabolic response to DCA. Our findings reveal significant changes in the 13C-labeled metabolite profiles of colon cancer cells upon DCA exposure. Detailed results of this investigation will be presented.
*This study was supported by the Welch Foundation grant ATβ2111β20220331 and the US Department of Defense CDMRP grants W81XWH-19-1-0741, W81XWH-21-1-0176, W81XWH-22-1-0105, W81XWH-22-1-0003, HT9425-23-1-0062, and HT9425-24-1-0287.
β
Presenters
-
Emmanuel Oche Ameh
- University of Texas at Dallas